Gloverlyn Berko

MS, MHC | Mental Health Counselor


  347 5th Ave Rm 1103, New York
     New York, 10016-5050
  866-232-7328    Maps & Directions
Gloverlyn Berko is a New York, New York based counselor who is specialized as Mental Health Counselor. Her current practice location is 347 5th Ave Rm 1103, New York. Patients can book an appointment with her at 866-232-7328.
Gloverlyn Berko is a licensed professional who helps individuals, couples, and families manage and overcome emotional, psychological, and behavioral challenges. She assess clients’ mental health conditions and develop personalized treatment plans to provide therapy for a range of mental health issues, including anxiety, depression, trauma, relationship issues, stress, grief, and life transitions.
Complete Profile:
Gloverlyn Berko speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Gloverlyn Berko
Specialization: Mental Health Counselor
Gender:Female
Credentials: MS, MHC
Accepts Medicare Assignment:No
Practice Address:347 5th Ave Rm 1103, New York,
New York, 10016-5050
Phone:866-232-7328
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1265252092
NPI Enumeration Date: 16 Oct, 2024
NPI Last Update On: 16 Oct, 2024

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 347 5th Ave Rm 1103,
New York, New York
Zip: 10016-5050
Phone Number: 866-232-7328
Patients can reach Gloverlyn Berko at 347 5th Ave Rm 1103, New York, New York or can call to book an appointment on 866-232-7328.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.

Comments/ Reviews: